Thiazolidinedione Use and Bone Loss in Older Diabetic Adults | Zendy

Ann V. Schwartz | Zendy; Deborah E. Sellmeyer | Zendy; Eric Vittinghoff | Zendy; Lisa Palermo | Zendy; Beata LeckaCzernik | Zendy; Kenneth R. Feingold | Zendy; Elsa S. Strotmeyer | Zendy; Helaine E. Resnick | Zendy; Laura Carbone | Zendy; Brock A. Beamer | Zendy; Seok Won Park | Zendy; Nancy E. Lane | Zendy; Tamara B. Harris | Zendy; Steven R. Cummings | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Thiazolidinedione Use and Bone Loss in Older Diabetic Adults

Author(s) -

Ann V. Schwartz,

Deborah E. Sellmeyer,

Eric Vittinghoff,

Lisa Palermo,

Beata LeckaCzernik,

Kenneth R. Feingold,

Elsa S. Strotmeyer,

Helaine E. Resnick,

Laura Carbone,

Brock A. Beamer,

Seok Won Park,

Nancy E. Lane,

Tamara B. Harris,

Steven R. Cummings

Publication year - 2006

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2005-2226

Subject(s) - thiazolidinedione , context (archaeology) , endocrinology , pioglitazone , medicine , rosiglitazone , peroxisome proliferator , peroxisome proliferator activated receptor , receptor , diabetes mellitus , type 2 diabetes , biology , paleontology

Activation of peroxisome proliferator-activated receptor-gamma by thiazolidinediones (TZDs) results in lower bone mass in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research